Healthcare · Medical Devices · NASDAQ
| Market cap | $1.56B |
|---|---|
| Trailing P/E | — |
| FCF yield | -7.2% |
| Revenue growth (YoY) | +7.9% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | -2208.7% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
Tandem Diabetes Care, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Apr 6, 2026 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Oct 7, 2025 |
| Josh Gottheimer | House | Sell | $1,001 - $15,000 | Apr 4, 2025 |
| Daniel Goldman | House | Sell | $1,001 - $15,000 | Aug 9, 2023 |
| Thomas MacArthur | House | Sell | $1,001 - $15,000 | Jun 1, 2015 |